Location
Global heart-lung machine market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024.
Global Heart-Lung Machine Market
Market Outline: Global Heart-Lung Machine Market
Heart-lung machine acts as a cardiopulmonary bypass that support the functioning of both heart and lungs during the open heart surgery. Heart-lung machine contains a chamber that receives the deoxygenated blood from body, oxygenates it, and supplies to all parts of body. These are most commonly used in coronary bypass heart surgery. Heart-lung machine is connected to patients with a series of tubes that are removed after the surgery when lungs and heart resume its functions.
Market Dynamics: Global Heart-Lung Machine Market
Increase in global geriatric population coupled with rise in prevalence of cardiovascular devices are anticipated to propel the global heart-lung machines market. Moreover, rise in awareness about the cardiovascular devices, increase in the R&D expenditure for the development of technologically advanced devices, sophisticated healthcare infrastructure, government initiations to rise in awareness about cardiovascular diseases among the people, and grow in healthcare expenditure are anticipated to surge the global heart-lung machine market over the forecast years. However, stringent regulations for the product approval, dearth of skilled professionals in the underdeveloped countries, less life-cycle of the products are dampen the growth of global heart-lung machine market.
Market Scope: Global Heart-Lung Machine Market
Global heart-lung machine market is segmented based on product type, application, and end user
Based on product type, market is segmented into the following:
- Double Roller Pump
- Single Roller Pump
Based on the application, market is segmented into the following:
- Acute Respiratory Failure Treatment
- Lung Transplantation Operations
- Cardiac Surgery
- Others
Based on the end user, the market is segmented into the following:
- Hospitals
- Clinics
- Others
Geography
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
Rest of MEA
Regional Analysis: Global Heart-Lung Machine Market
Geographically, global heart-lung machine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America heart-lung machine market is poised to grow due to rise in prevalence of cardiovascular disorders, increase in number of lung transplantation surgeries, and sophisticated healthcare infrastructure are fuel the market. Europe heart-lung machine market is driving by rise adoption of technologically advanced medical devices in the region, presence of huge number of market players, and increase in the R&D activities for the development of newer products are bolster the market. Asia Pacific heart-lung machine market has prominent share attributed to increase in the medical tourism in Asia Pacific region, rise in geriatric population in India, China, and Japan, and government initiations to increase the awareness about the cardiovascular disorders enhance the revenue of market
Competition Assessment: Global Heart-Lung Machine Market
Some of the players in the global heart-lung machine market include:
- Medtronic plc (Ireland)
- R. Bard, Inc. (U.S.)
- MAQUET GmbH & Co. KG. (Germany)
- Terumo Corporation (Japan)
- Sorin Group (Italy)
- Edward Lifesciences (U.S.)
- SynCardia Systems, LLC (U.S.)
- Braile Biomedica (Brazil)
- LivaNova plc (UK)
- Jarvik Heart, Inc. (U.S.)
GEOGRAPHY
hghLatin America Got Significant Share
Global Heart Lung Machine Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| Â [button icon="fa-magic" link="#ulp-c654SbFYO64MsOhu" target="_self" hover_type="enlarge" text="Request TOC" color="#ffffff" hover_color="#ffffff" hover_background_color="#1A3652" background_color="#1A3652" border_color="#1A3652"]Â Â |
Competition Assessment: Nerve Repair and Regeneration Market
Some of the players in the global nerve repair and regeneration market include:
- AxoGen Inc. (U.S.)
- Baxter International (U.S.)
- Medtronic (US)
- Cyberonics Inc. (U.S.)
- Integra Lifesciences Corporation (U.S.)
- Boston Scientific (US)
- Abbott Laboratories (US)
- LivaNova (UK)
- Baxter (US)
- AxoGen (US)
- Stryker (US)